Combination of two monoclonal antibodies with SOCS1 N- and C-terminal binding sites to address SOCS1 status in B cells and B-cell lymphoma.

Anti-SOCS1 antibody 4H1 may be useful in a molecular setting, but is disqualified as an immunohistochemical diagnostic tool due to its very broad non-specific binding.